Progestin Antagonist [EPC] - N0000175841

Name: Table of NDC products with progestin antagonist
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000175841
Pharmacologic Name	Progestin Antagonist
Pharmacologic Uses	progestin antagonist
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Progestin Antagonist

The following table contains 3 products whose active ingredient are classified under the same pharmacologic class Progestin Antagonist [EPC].

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
43393-001	Mifepristone	Non-Proprietary Name: Mifepristone	Tablet	Oral	Genbiopro, Inc.	ACTIVE
76346-073	Korlym	Non-Proprietary Name: Mifepristone	Tablet	Oral	Corcept Therapeutics	ACTIVE
83114-001	Mifepristone	Non-Proprietary Name: Mifepristone	Tablet	Oral	Pci Pharma Services Canada, Inc.	ACTIVE